Pfizer Inc

Covid cases surge in California – check symptoms and vaccine eligibility for LP.8.1 variant

California sees a rise in COVID-19 cases as the new LP.8.1 variant spreads. Learn about the latest vaccine updates, eligibility,…

September 5, 2025 20:15 IST

Why Pfizer scrapped obesity pill development: Weight-loss drug market shares explored

Pfizer has abandoned the development of the experimental oral weight-loss drug danuglipron.

April 15, 2025 09:36 IST

IsomAb announces Development Candidate nomination with Pfizer for Peripheral Arterial Disease

IsomAb has also entered into a strategic collaboration with Pfizer Ignite to support preclinical development and IND-enabling studies for ISM-001,…

October 16, 2024 15:22 IST

USFDA, drug approvals, Pfizer, RSV, RSV in infants, healthcare news, pharma news,

USFDA approves Pfizer’s vaccine for mothers to prevent RSV in infants

Moreover, the USFDA has asked the company to conduct postmarketing studies to assess the signal of serious risk of preterm…

August 22, 2023 14:10 IST

GSK, Pfizer, Sanofi, Zantac, cancer, health news, pharma news,

GSK, Pfizer, Sanofi get relief after court found claims of Zantac-linked cancer not ‘backed by science’

Zantac, first approved in 1983, became the world’s best-selling medicine in 1988 and one of the first-ever drugs to top…

December 7, 2022 15:06 IST

Pfizer, Pfizer India, patient assistance, health news, healthcare news,

Pfizer applies for FDA authorisation for omicron-retooled booster dose

According to the pharma major, this dose will come in the three-dose primary series for children 6 months through 4…

December 6, 2022 12:21 IST

LifeCell, HaystackAnalytics, genetic testing, Tuberculosis, omega TB, health news, diagnostics news,

Pfizer India inks partnership with Father Muller Research to award fellowships to younger scientists

Moreover, the bespoke fellowships will be a form of recognition and will enable young clinicians who want to pursue medical…

September 26, 2022 15:10 IST

Pfizer, Pfizer Inc, Influenza vaccines, mRNA vaccines, health news, pharma news,

Pfizer begins Phase III clinical trial of mRNA-based influenza vaccine

According to the company, the trial is being conducted to evaluate efficacy, safety, tolerability, and immunogenicity of the influenza vaccine.

September 14, 2022 17:05 IST

Myovant, Pfizer, endometriosis, pain management, menstrual pains, health news, pharma news,

USFDA approves Myovant & Pfizer’s Myfembree for management of moderate to severe pain associated with endometriosis

According to the companies, Myfembree is also approved for heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

August 8, 2022 13:22 IST

Pfizer India partners with Max Super Speciality Hospitals to give fellowship to young doctors

The biopharmaceutical major claims that the fellowship program will provide young clinicians and researchers at all 17 Max Speciality Hospitals…

July 15, 2022 19:32 IST

FDA OKs another Pfizer, Moderna COVID booster for 50 and up

The Food and Drug Administration’s decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at…

March 29, 2022 20:45 IST

GlaxoSmithKline, Pfizer, Haleon, Sensodyne, Voltaren, Panadol, Centrum

GlaxoSmithKline to rename consumer healthcare venture with Pfizer as ‘Haleon’

Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands, including Sensodyne, Voltaren, Panadol…

Updated: February 23, 2022 18:15 IST

US regulators give full approval to Pfizer Covid-19 vaccine

The move could lift public confidence in the shots and spur more companies, universities and local governments to make vaccinations…

August 23, 2021 21:43 IST

Covid-19 vaccine: Govt examining Pfizer’s request for indemnity, will take decision on merit, says VK Paul

At a press conference, Paul said, “Yes we are engaged with Pfizer and they have indicated the availability of a…

May 27, 2021 22:26 IST

Our vaccine highly effective on COVID-19 variant prevalent in India, suitable for 12 years and above: Pfizer to Govt

Another source privy to the discussions said that following recent meetings between the Indian government and Pfizer’s Chairman and CEO…

May 26, 2021 22:28 IST

While regulatory ease could be debated from either end, pricing and export freedom is a must.

Govt must free up Covid-19 vaccine pricing

It must heed Pfizer’s call; price caps, export controls will discourage pvt sector participation in India’s vaccination efforts

March 13, 2021 06:30 IST

world health organisation emergency use authorisation to pfizer vaccine

WHO gives ‘emergency validation’ to Pfizer-BioNTech corona vaccine, calls for equitable global access

The WHO, together with the GAVI Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI), are spearheading a global…

January 1, 2021 08:35 IST

Market Highlights: Sensex ends 680 pts higher, Nifty closes at 12,631; financials zoom, pharma, IT stocks bleed

Share Market News Today | Sensex, Nifty, Share Prices Highlights: Sensex and Nifty surged yet again on Tuesday, setting fresh…

Updated: November 10, 2020 16:25 IST

Related News

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

New Zealand visa application, visa police certificates, visa Regional Passport Office, Indian Ministry of External Affairs, Immigration New Zealand

New Zealand issues new rules for Indian national visa applicants

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

If alcohol is brought into the jurisdiction of GST, the states would lose autonomy over one of their most dependable tax sources.

Will alcohol get costlier after new GST rates? Govt clarifies

Motilal Oswal stock picks, M&M share price, HDFC Life stock

Motilal Oswal’s top 3 ‘Buy’ picks after GST rate cut with upto 17% upside potential

Tax based on retail price for tobacco may kick in before 40% levy

Industry7 min ago

The implementation of a new 40% tax on pan masala, cigarettes, and tobacco products will be based on their retail sale price (RSP) to prevent tax evasion and expand the tax base. This change is similar to the previous excise duty regime and will increase the tax burden for the sector. However, it may also lead to higher tax liabilities for manufacturers and distributors.

View all shorts